rAAV.hCNGA3 gene therapy

rAAV.hCNGA3 · STZ eyetrial

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for rAAV.hCNGA3 gene therapy, covering 2024-04-18 to 2024-04-18. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy of rAAV.hCNGA3 Gene Therapy in Patients With CNGA3-linked Achromatopsia [Phase 1, Phase 2]